Breaking News

U.S. FDA Grants Accelerated Approval for Bayer’s Sevabertinib as First-Line Therapy in Advanced HER2-Mutant NSCLC Following 75% Response Rate

Bayer announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for sevabertinib, an oral, targeted HER2 tyrosine kinase inhibitor (TKI), as a first-line treatment for...

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...

Novartis Receives European Commission Approval for Itvisma®️ for older patient with spinal muscular atrophy

Novartis announced that the European Commission has approved Itvisma® (onasemnogene abeparvovec) for the treatment of 5q spinal muscular atrophy (SMA) with a bi-allelic mutation...

Enhertu Becomes First HER2 Tumour-Agnostic Therapy Approved in Europe for solid tumours

AstraZeneca and Daiichi Sankyo  announced that the European Commission has approved Enhertu (trastuzumab deruxtecan) as a monotherapy for adult patients with unresectable or metastatic HER2-positive (IHC 3+) solid tumours...

Alembic’s New Gujarat Hub to Speed Up Medicine Supply

Alembic Pharmaceuticals Limited has marked a significant step forward in its logistics infrastructure with the launch of a new Central Stock Point (CSP) in Kheda,...

Union Health Minister Reviews Dengue Preparedness in Delhi

Union Health and Family Welfare Minister Shri J.P. Nadda convened a high-level meeting on July 1, 2026, to evaluate Delhi's readiness for the dengue season. Officials...

Have Your Say Before It’s Law: Health Ministry Invites Public Feedback on Pharmacy Bill

The Ministry of Health and Family Welfare has released an updated version of its proposed National Pharmacy Commission Bill, marking the next step in...

Mankind Pharma Announces Strategic Collaboration with Denovo Sciences to Advance AI-Driven Drug Discovery

Mankind Pharma Ltd, one of India’s leading pharmaceutical companies, announced a strategic collaboration with Denovo Sciences, a pioneer in artificial intelligence-driven therapeutics. This partnership...